Compare VOR & KOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VOR | KOP |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.6M | 536.4M |
| IPO Year | 2021 | 2005 |
| Metric | VOR | KOP |
|---|---|---|
| Price | $14.12 | $37.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $64.78 | $52.50 |
| AVG Volume (30 Days) | ★ 566.8K | 202.2K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | 2.86 | ★ 11.38 |
| EPS | N/A | ★ 2.74 |
| Revenue | N/A | ★ $1,879,300,000.00 |
| Revenue This Year | N/A | $4.24 |
| Revenue Next Year | N/A | $0.97 |
| P/E Ratio | ★ N/A | $13.61 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.13 | $23.54 |
| 52 Week High | $49.95 | $39.27 |
| Indicator | VOR | KOP |
|---|---|---|
| Relative Strength Index (RSI) | 46.61 | 62.80 |
| Support Level | $14.04 | $26.62 |
| Resistance Level | $14.73 | $39.27 |
| Average True Range (ATR) | 1.24 | 1.74 |
| MACD | -0.09 | -0.11 |
| Stochastic Oscillator | 14.12 | 69.13 |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Koppers Holdings Inc through its subsidiaries, manufactures and sells wood products, wood treatment chemicals, and carbon compounds used in markets such as railroad, aluminum and steel, agriculture, utilities, and residential lumber. The company is organized into three business segments: railroad and utility products and services, performance chemicals, and carbon materials and chemicals. Its product portfolio includes treated and untreated wood products like crossties used in railroads, wood preservation chemicals, and carbon compounds such as creosote used in the treatment of wood crossties, among others. The majority of its revenue comes from the company's railroad and utility products and services segment, and more than half of the company's revenue is earned in the United States.